Design Considerations for Nanotherapeutics in Oncology

Overview

Journal Nanomedicine

Publisher Elsevier

Specialties Biomedical Engineering
Biotechnology

Date 2015 Aug 19

PMID 26282377

Citations 91

Authors

Triantafyllos Stylianopoulos

Rakesh K Jain

Affiliations

Soon will be listed here.

Abstract

From The Clinical Editor: Advances in nanotechnology have seen the introduction of new treatment modalities for cancer. The principle of action using nanocarriers for drug delivery is based mostly on the Enhanced Permeability and Retention effect. This phenomenon however, can also be a hindrance. In this article, the authors performed an in-depth review on various nanoparticle platforms in cancer therapeutics. They also suggested options to improve drug delivery, in terms of carrier design.

Citing Articles

Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment.

Grancharova T, Zagorchev P, Pilicheva B J Funct Biomater. 2024; 15(8).

PMID: 39194645 PMC: 11355745. DOI: 10.3390/jfb15080207.

Single-Domain Antibodies as Antibody-Drug Conjugates: From Promise to Practice-A Systematic Review.

Medina Perez V, Baselga M, Schuhmacher A Cancers (Basel). 2024; 16(15).

PMID: 39123409 PMC: 11311928. DOI: 10.3390/cancers16152681.

Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy.

Mpekris F, Panagi M, Charalambous A, Voutouri C, Stylianopoulos T Cell Rep Med. 2024; 5(7):101626.

PMID: 38944037 PMC: 11293360. DOI: 10.1016/j.xcrm.2024.101626.

Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology.

Hristova-Panusheva K, Xenodochidis C, Georgieva M, Krasteva N Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931344 PMC: 11206252. DOI: 10.3390/ph17060677.

PLX038A, a long-acting SN-38, penetrates the blood-tumor-brain-barrier, accumulates and releases SN-38 in brain tumors to increase survival of tumor bearing mice.

Jung J, Schneider E, Zhang W, Song H, Zhang M, Chou W Sci Rep. 2024; 14(1):14175.

PMID: 38898077 PMC: 11187204. DOI: 10.1038/s41598-024-64186-2.

References

Zhu L, Kate P, Torchilin V . Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. ACS Nano. 2012; 6(4):3491-8. PMC: 3337349. DOI: 10.1021/nn300524f. View

Gentile F, Chiappini C, Fine D, Bhavane R, Peluccio M, Cheng M . The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J Biomech. 2008; 41(10):2312-8. DOI: 10.1016/j.jbiomech.2008.03.021. View

Akhter S, Ahmad I, Ahmad M, Ramazani F, Singh A, Rahman Z . Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets. 2013; 13(4):362-78. DOI: 10.2174/1568009611313040002. View

Lee H, Fonge H, Hoang B, Reilly R, Allen C . The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol Pharm. 2010; 7(4):1195-208. DOI: 10.1021/mp100038h. View

Wiig H, Swartz M . Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev. 2012; 92(3):1005-60. DOI: 10.1152/physrev.00037.2011. View

Thorek D, Tsourkas A . Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials. 2008; 29(26):3583-90. PMC: 2518173. DOI: 10.1016/j.biomaterials.2008.05.015. View

Peer D, Karp J, Hong S, Farokhzad O, Margalit R, Langer R . Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2008; 2(12):751-60. DOI: 10.1038/nnano.2007.387. View

Minchinton A, Tannock I . Drug penetration in solid tumours. Nat Rev Cancer. 2006; 6(8):583-92. DOI: 10.1038/nrc1893. View

Klibanov A, Maruyama K, Torchilin V, Huang L . Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990; 268(1):235-7. DOI: 10.1016/0014-5793(90)81016-h. View

10.

Stylianopoulos T, Jain R . Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc Natl Acad Sci U S A. 2013; 110(46):18632-7. PMC: 3832007. DOI: 10.1073/pnas.1318415110. View

11.

Gerlowski L, Jain R . Microvascular permeability of normal and neoplastic tissues. Microvasc Res. 1986; 31(3):288-305. DOI: 10.1016/0026-2862(86)90018-x. View

12.

Chen Q, Zhang Q, Liu J, Li L, Zhao W, Wang Y . [Multi-center prospective randomized trial on paclitaxel liposome and traditional taxol in the treatment of breast cancer and non-small-cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2003; 25(2):190-2. View

13.

Sugahara K, Teesalu T, Karmali P, Kotamraju V, Agemy L, Greenwald D . Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science. 2010; 328(5981):1031-5. PMC: 2881692. DOI: 10.1126/science.1183057. View

14.

Stylianopoulos T, Martin J, Chauhan V, Jain S, Diop-Frimpong B, Bardeesy N . Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A. 2012; 109(38):15101-8. PMC: 3458380. DOI: 10.1073/pnas.1213353109. View

15.

Jain R . Barriers to drug delivery in solid tumors. Sci Am. 1994; 271(1):58-65. DOI: 10.1038/scientificamerican0794-58. View

16.

Nugent L, Jain R . Extravascular diffusion in normal and neoplastic tissues. Cancer Res. 1984; 44(1):238-44. View

17.

Prabhakar U, Maeda H, Jain R, Sevick-Muraca E, Zamboni W, Farokhzad O . Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013; 73(8):2412-7. PMC: 3916009. DOI: 10.1158/0008-5472.CAN-12-4561. View

18.

Campbell R, Fukumura D, Brown E, Mazzola L, Izumi Y, Jain R . Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res. 2002; 62(23):6831-6. View

19.

Pluen A, Netti P, Jain R, Berk D . Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. Biophys J. 1999; 77(1):542-52. PMC: 1300351. DOI: 10.1016/S0006-3495(99)76911-0. View

20.

Zhou Z, Ma X, Jin E, Tang J, Sui M, Shen Y . Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery. Biomaterials. 2013; 34(22):5722-35. DOI: 10.1016/j.biomaterials.2013.04.012. View